John LaMattina - Frequency Therapeutics Advisor Board
| FREQDelisted Stock | USD 0.52 0.03 5.45% |
Insider
John LaMattina is Advisor Board of Frequency Therapeutics
| Age | 73 |
| Phone | 781 315-4600 |
| Web | www.frequencytx.com |
Frequency Therapeutics Management Efficiency
The company has return on total asset (ROA) of (0.425) % which means that it has lost $0.425 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.9993) %, meaning that it created substantial loss on money invested by shareholders. Frequency Therapeutics' management efficiency ratios could be used to measure how well Frequency Therapeutics manages its routine affairs as well as how well it operates its assets and liabilities.Frequency Therapeutics currently holds 42.95 M in liabilities with Debt to Equity (D/E) ratio of 0.47, which is about average as compared to similar companies. Frequency Therapeutics has a current ratio of 6.63, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Frequency Therapeutics' use of debt, we should always consider it together with its cash and equity.
Similar Executives
| Showing other executives | INSIDER Age | ||
| Erin JD | Shattuck Labs | 44 | |
| Jo PalmerPhillips | Eliem Therapeutics | N/A | |
| Robert MBA | Eliem Therapeutics | 56 | |
| Joseph Ciavarella | Portage Biotech | N/A | |
| Jonathan MS | Absci Corp | N/A | |
| David Myles | Olema Pharmaceuticals | 61 | |
| Jill Howe | Lineage Cell Therapeutics | 48 | |
| Peter Kushner | Olema Pharmaceuticals | 85 | |
| Arnold Levine | Pmv Pharmaceuticals | 84 | |
| Michele MBA | Prelude Therapeutics | N/A | |
| Winston MBA | Pmv Pharmaceuticals | 48 | |
| Jack Gold | Absci Corp | N/A | |
| James JD | Eliem Therapeutics | 58 | |
| Leila MD | Pmv Pharmaceuticals | 61 | |
| Andrew MBA | Shattuck Labs | 38 | |
| Thomas Shenk | Pmv Pharmaceuticals | 77 | |
| Steven Martin | Armata Pharmaceuticals | 63 | |
| MSc MBA | Passage Bio | 55 | |
| Ioana Hone | Lineage Cell Therapeutics | N/A | |
| Mihail MD | MAIA Biotechnology | 65 | |
| JD MBA | Monte Rosa Therapeutics | 46 | |
Management Performance
| Return On Equity | -1.0 | |||
| Return On Asset | -0.42 |
Frequency Therapeutics Leadership Team
Elected by the shareholders, the Frequency Therapeutics' board of directors comprises two types of representatives: Frequency Therapeutics inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Frequency. The board's role is to monitor Frequency Therapeutics' management team and ensure that shareholders' interests are well served. Frequency Therapeutics' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Frequency Therapeutics' outside directors are responsible for providing unbiased perspectives on the board's policies.
| John LaMattina, Advisor Board | ||
| David Lucchino, President, CoFounder | ||
| James Abely, Associate Sec | ||
| Christopher Loose, CoFounder Officer | ||
| Jason Glashow, Sr Affairs | ||
| William MD, VP Medicine | ||
| Quentin McCubbin, Chief Officer | ||
| Wendy Arnold, Chief Officer | ||
| Carl LeBel, Chief Officer | ||
| Dana MD, Chief Officer |
Frequency Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Frequency Therapeutics a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -1.0 | |||
| Return On Asset | -0.42 | |||
| Current Valuation | 512.86 M | |||
| Shares Outstanding | 36.52 M | |||
| Shares Owned By Insiders | 7.26 % | |||
| Shares Owned By Institutions | 14.12 % | |||
| Number Of Shares Shorted | 365.89 K | |||
| Price To Earning | (7.43) X | |||
| Price To Book | 0.91 X | |||
| Price To Sales | 7.50 X |
Pair Trading with Frequency Therapeutics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Frequency Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Frequency Therapeutics will appreciate offsetting losses from the drop in the long position's value.Moving against Frequency Stock
| 0.57 | PBCRY | Bank Central Asia | PairCorr |
| 0.47 | PPERY | Bank Mandiri Persero | PairCorr |
| 0.43 | BKRKY | Bank Rakyat | PairCorr |
| 0.43 | PPERF | Bank Mandiri Persero | PairCorr |
| 0.41 | PBCRF | PT Bank Central | PairCorr |
The ability to find closely correlated positions to Frequency Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Frequency Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Frequency Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Frequency Therapeutics to buy it.
The correlation of Frequency Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Frequency Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Frequency Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Frequency Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Other Consideration for investing in Frequency Stock
If you are still planning to invest in Frequency Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Frequency Therapeutics' history and understand the potential risks before investing.
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities |